On 25- 26 November, the 15th European Network for the Study of Adrenal Tumours (ENSAT) Scientific Meeting returned to Birmingham after many years to be hosted by IMSR’s Professor Wiebke Arlt and her team for a very successful event.
Attendees came from 22 countries to participate in the two day conference, which began on the Friday at the Everyman Cinema, Mailbox, where there was a packed programme of oral presentations. Delegates enjoyed networking in the evening at the Festive Awards Dinner in the Banqueting Suite, Council House, Birmingham.
Day 2 was held at the Medical School, University of Birmingham and consisted of working groups, oral communications and guided poster sessions. There was also a parallel patient strand programme in collaboration with ACC Support UK. Patients attending this meeting were given the opportunity to join the conference for some of the sessions.
The meeting is entirely submission-driven and science from the whole of Europe and beyond was presented, focussing on the four different entities, non-aldosterone producing adrenocortical adenoma (NAPACA), adrenocortical carcinoma (ACC), pheochromocytoma (PHAEO) and primary aldosteronism (APA).
In addition to ENSAT, the conference was supported by the European Society of Endocrinology, HRA Pharma, Millendo Therapeutics and Alta Bioscience.
